TINA CUDA: Open Payments
NPI 1467773648 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 21 payments from 9 companies in 2025. Trend: 2023 $342 · 2024 $677 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $103 |
| PFIZER INC. | 5 | $79 |
| Novo Nordisk Inc | 3 | $60 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Abbott Laboratories | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: BOTOX, ELIQUIS, SHINGRIX, Wegovy, NURTEC ODT, QULIPTA, KEVEYIS, XIFAXAN.
Industry payments across NY — which companies pay providers there.
